Immunotherapy at the 10th European Lung Cancer Conference 2016
OS rates and prognostic categories for BRAF-mutated melanoma when treated with combination therapy
When can checkpoint inhibitors be used to treat urothelial carcinoma?
Toxicities of immunotherapy and patient expectations in lung cancer
ASCO 2016 highlights for immunotherapy